- Home
- GNLX vs FIRY Comparison
GNLX vs FIRY Comparison
Compare GNLX & FIRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$2.99
N/A
Current Price
$9.74
Company Overview
Basic Information| Metric | GNLX | FIRY |
|---|---|---|
| Founded | 2001 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 133.0M | 148.6M |
| IPO Year | 2022 | 2020 |
Fundamental Metrics
Financial Performance| Metric | GNLX | FIRY |
|---|---|---|
| Price | $2.99 | $9.74 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $17.25 | N/A |
| AVG Volume (30 Days) | ★ 189.2K | 135.9K |
| Earning Date | 05-12-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 9.47 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $8,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.29 | $9.39 |
| 52 Week High | $8.54 | $10.74 |
Technical Indicators
Market Signals| Indicator | GNLX | FIRY |
|---|---|---|
| Relative Strength Index (RSI) | 54.39 | N/A |
| Support Level | $2.36 | N/A |
| Resistance Level | $3.03 | N/A |
| Average True Range (ATR) | 0.18 | 0.00 |
| MACD | 0.00 | 0.00 |
| Stochastic Oscillator | 76.98 | 0.00 |
Price Performance
Historical Comparison GNLX
FIRY
About GNLX Genelux Corporation
Genelux Corp is a late-stage biopharmaceutical firm focused on developing oncolytic viral immunotherapies for cancer. Its pipeline includes clinical and preclinical candidates designed to target tumor cells and stimulate an immune response against tumor-specific antigens. The company is focused on the development of next-generation oncolytic viral immunotherapies that are designed to generate a personalized multi-prong attack to overwhelm a tumor's sophisticated defense mechanisms.